Schreiner MediPharm adds LM labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling technology for over 60 years, has introduced low migration labels for use with plastic containers and prevent package-to-product migration of molecules from solvents and substances in inks, adhesives and film materials.

Schreiner MediPharm said package-to-product migration is especially relevant in the case of soft plastics, like eye drops in soft plastic bottles which might be contaminated or their effectiveness impaired

Schreiner MediPharm said plastic containers are increasingly being used in lieu of glass in primary pharmaceutical packaging.

A variety of factors, such as cost-effectiveness, break resistance and convenience, has led to the rising prominence of plastics in pharmaceutical packaging containers. However, when compared to glass, Schreiner MediPharm said plastic containers bring an increased risk of package-to-product migration, meaning that molecules from solvents and other substances contained in inks, adhesives, and film materials could potentially migrate through the packaging over time.

This is especially relevant in the case of soft plastics, like eye drops in soft plastic bottles which might be contaminated or their effectiveness impaired.

Schreiner MediPharm’s low migration label offering for plastic containers address this potential downside in a manner that does not compromise the packaged product. Utilizing qualified adhesive systems, materials and inks, specialty labels can be customized to suit a wide range of plastic container packaging applications.

Schreiner MediPharm conducted a study with a renowned, independent test institute to analyze, calculate and evaluate the migration tendency of various label compositions.  The results make it possible to specifically develop low migration label products for each application, without any major expenditure of time or investment by the pharmaceutical manufacturer.

Gene Dul, president of Schreiner MediPharm US, said: ‘Schreiner MediPharm’s customized low migration labels can increase the likelihood of a smooth approval process from drug administration authorities, which can lead to a shorter overall time to market.

‘As a growing number of primary packaging containers in the pharmaceutical industry are comprised of plastic, solutions such as these will become increasingly attractive to manufacturers looking to avoid approval slowdowns.’

Read a review of the pharmaceutical market from Labels & Labeling, issue 5, 2014 here